Role of p16 INK4A in replicative senescence and DNA damage-induced premature senescence in p53-deficient human cells

Biochemistry Research International

Volumn , Issue , 2012, Pages

  Mirzayans, Razmik ^a   Andrais, Bonnie ^a   Hansen, Gavin ^a   Murray, David ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866245250     PISSN: 20902247     EISSN: 20902255     Source Type: Journal    
DOI: 10.1155/2012/951574     Document Type: Review

References (68)

1. Huschtscha L. I., Reddel R. R., p16 INK4a and the control of cellular proliferative life span. Carcinogenesis 1999 20 6 921 926 2-s2.0-0033049828 10.1093/carcin/20.6.921 (Pubitemid 29263731)
2. Herbig U., Jobling W. A., Chen B. P. C., Chen D. J., Sedivy J. M., Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21 CIP1, but not p16 INK4a. Molecular Cell 2004 14 4 501 513 2-s2.0-2442511752 10.1016/S1097-2765(04)00256-4 (Pubitemid 38648803)
3. Zhang H., Molecular signaling and genetic pathways of senescence: its role in tumorigenesis and aging. Journal of Cellular Physiology 2007 210 3 567 574 2-s2.0-33846687101 10.1002/jcp.20919 (Pubitemid 46188287)
4. Vergel M., Carnero A., Bypassing cellular senescence by genetic screening tools. Clinical and Translational Oncology 2010 12 6 410 417 2-s2.0-77955966139 10.1007/s12094-010-0528-2
5. Rajaraman R., Guernsey D. L., Rajaraman M. M., Rajaraman S. R., Stem cells, senescence, neosis and self-renewal in cancer. Cell Biology International 2005 29 12 1084 1097 2-s2.0-28444483264 (Pubitemid 41739835)
6. Mirzayans R., Andrais B., Scott A., Murray D., New insights into p53 signaling and cancer-cell response to DNA damage: implications for cancer therapy. Journal of Biomedicine and Biotechnology 2012 2012 16 170325 10.1155/2012/170325
7. Mirzayans R., Murray D., Garvey R. B., Cellular senescence: implications for cancer therapy. New Research on Cell Aging 2007 New York, NY, USA Nova Science 1 64
8. Beauséjour C. M., Krtolica A., Galimi F., Narita M., Lowe S. W., Yaswen P., Campisi J., Reversal of human cellular senescence: roles of the p53 and p16 pathways. The EMBO Journal 2003 22 16 4212 4222 2-s2.0-0041966056 10.1093/emboj/cdg417 (Pubitemid 37021749)
9. Roninson I. B., Tumor cell senescence in cancer treatment. Cancer Research 2003 63 11 2705 2715 2-s2.0-0038277105 (Pubitemid 36667137)
10. Itahana K., Zou Y., Itahana Y., Martinez J. L., Beausejour C., Jacobs J. J. L., Van Lohuizen M., Band V., Campisi J., Dimri G. P., Control of the replicative life span of human fibroblasts by p16 and the polycomb protein Bmi-1. Molecular and Cellular Biology 2003 23 1 389 401 2-s2.0-0037214382 10.1128/MCB.23.1.389-401.2003 (Pubitemid 36008529)
11. Chen J., Huang X., Halicka D., Brodsky S., Avram A., Eskander J., Bloomgarden N. A., Darzynkiewicz Z., Goligorsky M. S., Contribution of p16 INK4a and p21 CIP1 pathways to induction of premature senescence of human endothelial cells: permissive role of p53. American Journal of Physiology 2006 290 4 H1575 H1586 2-s2.0-33646096244 10.1152/ajpheart.00364.2005
12. Kunieda T., Minamino T., Nishi J. I., Tateno K., Oyama T., Katsuno T., Miyauchi H., Orimo M., Okada S., Takamura M., Nagai T., Kaneko S., Komuro I., Angiotensin II induces premature senescence of vascular smooth muscle cells and accelerates the development of atherosclerosis via a p21-dependent pathway. Circulation 2006 114 9 953 960 2-s2.0-33748351173 10.1161/CIRCULATIONAHA.106. 626606 (Pubitemid 44337139)
13. Sviderskaya E. V., Gray-Schopfer V. C., Hill S. P., Smit N. P., Evans-Whipp T. J., Bond J., Hill L., Bataille V., Peters G., Kipling D., Wynford-Thomas D., Bennett D. C., p16/cyclin-dependent kinase inhibitor 2A deficiency in human melanocyte senescence, apoptosis, and immortalization: possible implications for melanoma progression. Journal of the National Cancer Institute 2003 95 10 723 732 2-s2.0-0037941546 (Pubitemid 36665500)
14. Freedman D. A., Folkman J., CDK2 translational down-regulation during endothelial senescence. Experimental Cell Research 2005 307 1 118 130 2-s2.0-19544392134 10.1016/j.yexcr.2005.03.025 (Pubitemid 40732738)
15. Robertson K. D., Jones P. A., Tissue-specific alternative splicing in the human INK4a/ARF cell cycle regulatory locus. Oncogene 1999 18 26 3810 3820 2-s2.0-0033166440 10.1038/sj.onc.1202737 (Pubitemid 29358559)
16. Ortega S., Malumbres M., Barbacid M., Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochimica et Biophysica Acta 2002 1602 1 73 87 2-s2.0-0037075887 10.1016/S0304-419X(02)00037-9 (Pubitemid 34311901)
17. Jacobs J. J. L., de Lange T., p16 INK4a as a second effector of the telomere damage pathway. Cell Cycle 2005 4 10 1364 1368 2-s2.0-26444602415 (Pubitemid 41437123)
18. Jacobs J. J. L., Keblusek P., Robanus-Maandag E., Kristel P., Lingbeek M., Nederlof P. M., Van Welsem T., Van De Vijver M. J., Koh E. Y., Daley G. Q., Van Lohuizen M., Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19 ARF) and is amplified in a subset of human breast cancers. Nature Genetics 2000 26 3 291 299 2-s2.0-0033764030 10.1038/81583
19. Gil J., Bernard D., Martínez D., Beach D., Polycomb CBX7 has a unifying role in cellular lifespan. Nature Cell Biology 2004 6 1 67 72 2-s2.0-1342332096 10.1038/ncb1077 (Pubitemid 38425732)
20. Jacobs J. L., Kieboom K., Marino S., DePinho R. A., van Lohuizen M., The oncogene and polycombgroup gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 1999 397 6715 164 168 2-s2.0-0033552813 10.1038/16476 (Pubitemid 29050921)
21. Jung J. W., Lee S., Seo M. S., Park S. B., Kurtz A., Kang S. K., Kang K. S., Histone deacetylase controls adult stem cell aging by balancing the expression of polycomb genes and jumonji domain containing 3. Cellular and Molecular Life Sciences 2010 67 7 1165 1176 2-s2.0-77950602854 10.1007/s00018-009-0242-9
22. Feng Y., Wang X., Xu L., The transcription factor ZBP-89 suppresses p16 expression through a histone modification mechanism to affect cell senescence. FEBS Journal 2009 276 15 4197 4206 2-s2.0-68149182343 10.1111/j.1742-4658.2009. 07128.x
23. Rayess H., Wang M. B., Srivatsan E. S., Cellular senescence and tumor suppressor gene p16. International Journal of Cancer 2012 130 8 1715 1725 2-s2.0-84857504660 10.1002/ijc.27316
24. Hernández-Vargas H., Ballestar E., Carmona-Saez P., Von Kobbe C., Bañón-Rodríguez I., Esteller M., Moreno-Bueno G., Palacios J., Transcriptional profiling of MCF7 breast cancer cells in response to 5-fluorouracil: relationship with cell cycle changes and apoptosis, and identification of novel targets of p53. International Journal of Cancer 2006 119 5 1164 1175 2-s2.0-33746437215 10.1002/ijc.21938 (Pubitemid 44121416)
25. Alani R. M., Young A. Z., Shifflett C. B., Id1 regulation of cellular senescence through transcriptional repression of p16/Ink4a. Proceedings of the National Academy of Sciences of the United States of America 2001 98 14 7812 7816 2-s2.0-0034933793 10.1073/pnas.141235398 (Pubitemid 32642643)
26. Polsky D., Young A. Z., Busam K. J., Alani R. M., The transcriptional repressor of p16/Ink4a, Id1, is up-regulated in early melanomas. Cancer Research 2001 61 16 6008 6011 2-s2.0-0035881619 (Pubitemid 32762529)
27. Leong W. F., Chau J. F. L., Li B., p53 deficiency leads to compensatory up-regulation of p16 INK4a. Molecular Cancer Research 2009 7 3 354 360 2-s2.0-62549158651 10.1158/1541-7786.MCR-08-0373
28. Serrano M., Hannon G. J., Beach D., A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993 366 6456 704 707 2-s2.0-0027769876 10.1038/366704a0 (Pubitemid 24036021)
29. Parry D., Bates S., Mann D. J., Peters G., Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16 INK4/MTS1 tumour suppressor gene product. The EMBO Journal 1995 14 3 503 511 2-s2.0-0028869884
30. Sherr C. J., McCormick F., The RB and p53 pathways in cancer. Cancer Cell 2002 2 2 103 112 2-s2.0-0001510491 10.1016/S1535-6108(02)00102-2 (Pubitemid 41039110)
31. Harada H., Nakagavva K., Iwata S., Saito M., Kumon Y., Sakaki S., Sato K., Hamada K., Restoration of wild-type p16 down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human gliomas. Cancer Research 1999 59 15 3783 3789 2-s2.0-0033178714 (Pubitemid 29381887)
32. Castellano M., Pollock P. M., Walters M. K., Sparrow L. E., Down L. M., Gabrielli B. G., Parsons P. G., Hayward N. K., CDKN2A/p16 is inactivated in most melanoma cell lines. Cancer Research 1997 57 21 4868 4875 2-s2.0-0030728259 (Pubitemid 27468996)
33. Fåhraeus R., Lane D. P., The p16 INK4a tumour suppressor protein inhibits α v β 3 integrin-mediated cell spreading on vitronectin by blocking PKC-dependent localization of α v β 3 to focal contacts. The EMBO Journal 1999 18 8 2106 2118 2-s2.0-0033561310 (Pubitemid 29179168)
34. Vojta P. J., Barrett J. C., Genetic analysis of cellular senescence. Biochimica et Biophysica Acta 1995 1242 1 29 41 2-s2.0-0029090969 10.1016/0304-419X(95)00002-W
35. Sandig V., Brand K., Herwig S., Lukas J., Bartek J., Strauss M., Adenovirally transferred p16 INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death. Nature Medicine 1997 3 3 313 319 2-s2.0-0030614944 10.1038/nm0397-313 (Pubitemid 27112929)
36. Naruse I., Heike Y., Hama S., Mori M., Saijo N., High concentrations of recombinant adenovirus expressing p16 INK4a gene induces apoptosis in lung cancer cell lines. Anticancer Research 1998 18 6 A 4275 4282 2-s2.0-0032425707 (Pubitemid 29043645)
37. Plath T., Detjen K., Welzel M., Von Marschall Z., Murphy D., Schirner M., Wiedenmann B., Rosewicz S., A novel function for the tumor suppressor p16 INK4a: induction of anoikis via upregulation of the α 5 β 1 fibronectin receptor. Journal of Cell Biology 2000 150 6 1467 1477 2-s2.0-0034683576 10.1083/jcb.150.6.1467
38. Wolff B., Naumann M., INK4 cell cycle inhibitors direct transcriptional inactivation of NF- κ B. Oncogene 1999 18 16 2663 2666 2-s2.0-0033594397 10.1038/sj.onc.1202617 (Pubitemid 29216690)
39. Fang X., Jin X., Xu H. J., Liu L., Peng H. Q., Hogg D., Roth J. A., Yu Y., Xu F., Bast R. C., Mills G. B., Expression of p16 induces transcriptional downregulation of the RB gene. Oncogene 1998 16 1 1 8 2-s2.0-15144341364 (Pubitemid 28045038)
40. Huschtscha L. I., Moore J. D., Noble J. R., Campbell H. G., Royds J. A., Braithwaite A. W., Reddel R. R., Normal human mammary epithelial cells proliferate rapidly in the presence of elevated levels of the tumor suppressors p53 and p21 WAF1/CIP1. Journal of Cell Science 2009 122 16 2989 2995 2-s2.0-70350010305 10.1242/jcs.044107
41. Hu H., Li Z., Chen J., Wang D., Ma J., Wang W., Li J., Wu H., Li L., Wu M., Qian Q., Chen J., Su C., P16 reactivation induces anoikis and exhibits antitumour potency by downregulating Akt/survivin signalling in hepatocellular carcinoma cells. Gut 2011 60 5 710 721 2-s2.0-79953755891 10.1136/gut.2010. 220020
42. Mirzayans R., Andrais B., Scott A., Paterson M. C., Murray D., Single-cell analysis of p16 INK4a and p21 WAF1 expression suggests distinct mechanisms of senescence in normal human and Li-Fraumeni syndrome fibroblasts. Journal of Cellular Physiology 2010 223 1 57 67 2-s2.0-75749155861 10.1002/jcp.22002
43. Al-Mohanna M. A., Manogaran P. S., Al-Mukhalafi Z., Al-Hussein K. A., Aboussekhra A., The tumor suppressor p16 INK4a gene is a regulator of apoptosis induced by ultraviolet light and cisplatin. Oncogene 2004 23 1 201 212 2-s2.0-0942301170 10.1038/sj.onc.1206927 (Pubitemid 38142254)
44. Zhang D., Shimizu T., Araki N., Hirota T., Yoshie M., Ogawa K., Nakagata N., Takeya M., Saya H., Aurora A overexpression induces cellular senescence in mammary gland hyperplastic tumors developed in p53-deficient mice. Oncogene 2008 27 31 4305 4314 2-s2.0-47549118837 10.1038/onc.2008.76 (Pubitemid 352010006)
45. Yamakoshi K., Takahashi A., Hirota F., Nakayama R., Ishimaru N., Kubo Y., Mann D. J., Ohmura M., Hirao A., Saya H., Arase S., Hayashi Y., Nakao K., Matsumoto M., Ohtani N., Hara E., Real-time in vivo imaging of p16 INK4a reveals cross talk with p53. Journal of Cell Biology 2009 186 3 393 407 2-s2.0-68549127064 10.1083/jcb.200904105
46. Alcorta D. A., Xiong Y., Phelps D., Hannon G., Beach D., Barrett J. C., Involvement of the cyclin-dependent kinase inhibitor p16 INK4a in replicative senescence of normal human fibroblasts. Proceedings of the National Academy of Sciences of the United States of America 1996 93 24 13742 13747 2-s2.0-0030477686 10.1073/pnas.93.24.13742 (Pubitemid 26424190)
47. Stein G. H., Drullinger L. F., Soulard A., Dulić V., Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Molecular and Cellular Biology 1999 19 3 2109 2117 2-s2.0-0033013980 (Pubitemid 29098269)
48. Brookes S., Rowe J., Gutierrez Del Arroyo A., Bond J., Peters G., Contribution of p16 INK4a to replicative senescence of human fibroblasts. Experimental Cell Research 2004 298 2 549 559 2-s2.0-3242708498 10.1016/j.yexcr.2004.04.035 (Pubitemid 38950870)
49. Cánepa E. T., Scassa M. E., Ceruti J. M., Marazita M. C., Carcagno A. L., Sirkin P. F., Ogara M. F., INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions. IUBMB Life 2007 59 7 419 426 2-s2.0-34547223720 10.1080/15216540701488358 (Pubitemid 47123998)
50. Barley R. D. C., Enns L., Paterson M. C., Mirzayans R., Aberrant p21 WAF1 -dependent growth arrest as the possible mechanism of abnormal resistance to ultraviolet light cytotoxicity in Li-Fraumeni syndrome fibroblast strains heterozygous for TP53 mutations. Oncogene 1998 17 5 533 543 2-s2.0-0032490717 (Pubitemid 28401022)
51. Mirzayans R., Severin D., Murray D., Relationship between DNA double-strand break rejoining and cell survival after exposure to ionizing radiation in human fibroblast strains with differing ATM/p53 status: implications for evaluation of clinical radiosensitivity. International Journal of Radiation Oncology Biology Physics 2006 66 5 1498 1505 2-s2.0-33751171564 10.1016/j.ijrobp.2006.08.064
52. Vaziri H., West M. D., Allsopp R. C., Davison T. S., Wu Y. S., Arrowsmith C. H., Poirier G. G., Benchimol S., ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase. The EMBO Journal 1997 16 19 6018 6033 2-s2.0-0030761351 10.1093/emboj/16.19.6018 (Pubitemid 27427297)
53. Mirzayans R., Scott A., Andrais B., Pollock S., Murray D., Ultraviolet light exposure triggers nuclear accumulation of p21 WAF1 and accelerated senescence in human normal and nucleotide excision repair-deficient fibroblast strains. Journal of Cellular Physiology 2008 215 1 55 67 2-s2.0-39149096301 10.1002/jcp.21284 (Pubitemid 351363191)
54. Nobori T., Miura K., Wu D. J., Lois A., Takabayashi K., Carson D. A., Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 1994 368 6473 753 756 2-s2.0-0028275733 10.1038/368753a0 (Pubitemid 24153417)
55. Kamb A., Gruis N. A., Weaver-Feldhaus J., Liu Q., Harshman K., Tavtigian S. V., Stockert E., Day R. S., Johnson B. E., Skolnick M. H., A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994 264 5157 436 440 2-s2.0-0028121279
56. Spruck C. H. 3rd, Gonzalez-Zulueta M., Shibata A., Simoneau A. R., Lin-M. F., Gonzales F., Tsai Y. C., Jones P. A., p16 gene in uncultured tumours. Nature 1994 370 6486 183 184 2-s2.0-0028070985 10.1038/370183a0 (Pubitemid 24236761)
57. Chang B. D., Broude E. V., Dokmanovic M., Zhu H., Ruth A., Xuan Y., Kandel E. S., Lausch E., Christov K., Roninson I. B., A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents. Cancer Research 1999 59 15 3761 3767 2-s2.0-17444388849 (Pubitemid 29381884)
58. Mirzayans R., Scott A., Cameron M., Murray D., Induction of accelerated senescence by γ radiation in human solid tumor-derived cell lines expressing wild-type TP53. Radiation Research 2005 163 1 53 62 2-s2.0-11144290056 10.1667/RR3280 (Pubitemid 40039944)
59. Myöhänen S. K., Baylin S. B., Herman J. G., Hypermethylation can selectively silence individual p16 INK4A alleles in neoplasia. Cancer Research 1998 58 4 591 593 2-s2.0-0343953594 (Pubitemid 28099461)
60. Zhang W., Zhu J., Bai J., Jiang H., Liu F., Liu A., Liu P., Ji G., Guan R., Sun D., Ji W., Yu Y., Jin Y., Meng X., Fu S., Comparison of the inhibitory effects of three transcriptional variants of CDKN2A in human lung cancer cell line A549. Journal of Experimental and Clinical Cancer Research 2010 29 1, article 74 2-s2.0-77953592117 10.1186/1756-9966-29-74
61. Jones K. R., Elmore L. W., Jackson-Cook C., Demasters G., Povirk L. F., Holt S. E., Gewirtz D. A., p53-dependent accelerated senescence induced by ionizing radiation in breast tumour cells. International Journal of Radiation Biology 2005 81 6 445 458 2-s2.0-27844578432 10.1080/09553000500168549 (Pubitemid 41657561)
62. Wang M., Morsbach F., Sander D., Gheorghiu L., Nanda A., Benes C., Kriegs M., Krause M., Dikomey E., Baumann M., Dahm-Daphi J., Settleman J., Willers H., EGF receptor inhibition radiosensitizes NSCLC cells by inducing senescence in cells sustaining DNA double-strand breaks. Cancer Research 2011 71 19 6261 6269 2-s2.0-80053349458 10.1158/0008-5472.CAN-11-0213
63. Reed J. A., Loganzo F., Shea C. R., Walker G. J., Flores J. F., Glendening J. M., Bogdany J. K., Shiel M. J., Haluska F. G., Fountain J. W., Albino A. P., Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression. Cancer Research 1995 55 13 2713 2718 2-s2.0-0028981085
64. Abd Elmageed Z. Y., Gaur R. L., Williams M., Abdraboh M. E., Rao P. N., Raj M. H., Ismail F. M., Ouhtit A., Characterization of coordinated immediate responses by p16 INK4a and p53 pathways in UVB-irradiated human skin cells. The Journal of Investigative Dermatology 2009 129 1 175 183 2-s2.0-58149332171 10.1038/jid.2008.208
65. Hollestelle A., Nagel J. H. A., Smid M., Lam S., Elstrodt F., Wasielewski M., Ng S. S., French P. J., Peeters J. K., Rozendaal M. J., Riaz M., Koopman D. G., Ten Hagen T. L. M., De Leeuw B. H. C. G. M., Zwarthoff E. C., Teunisse A., Van Der Spek P. J., Klijn J. G. M., Dinjens W. N. M., Ethier S. P., Clevers H., Jochemsen A. G., Den Bakker M. A., Foekens J. A., Martens J. W. M., Schutte M., Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines. Breast Cancer Research and Treatment 2010 121 1 53 64 2-s2.0-77951295615 10.1007/s10549-009-0460-8
66. Galmarini C. M., Falette N., Tabone E., Levrat C., Britten R., Voorzanger-Rousselot N., Roesch-Gateau O., Vanier-Viornery A., Puisieux A., Dumontet C., Inactivation of wild-type p53 by a dominant negative mutant renders MCF-7 cells resistant to tubulin-binding agent cytotoxicity. British Journal of Cancer 2001 85 6 902 908 2-s2.0-0035860132 10.1054/bjoc.2001.2017 (Pubitemid 33010560)
67. Ostrakhovitch E. A., Olsson P. E., Von Hofsten J., Cherian M. G., P53 mediated regulation of metallothionein transcription in breast cancer cells. Journal of Cellular Biochemistry 2007 102 6 1571 1583 2-s2.0-36849074146 10.1002/jcb.21381 (Pubitemid 350223957)
68. Robles S. J., Adami G. R., Agents that cause DNA double strand breaks lead to p16 INK4a enrichment and the premature senescence of normal fibroblasts. Oncogene 1998 16 9 1113 1123 2-s2.0-0032485213 (Pubitemid 28127510)